4//SEC Filing
AMAG PHARMACEUTICALS INC. 4
Accession 0001179110-14-003973
CIK 0000792977operating
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 5:39 PM ET
Size
7.6 KB
Accession
0001179110-14-003973
Insider Transaction Report
Form 4
White Christopher G
Chief Business Officer and SVP
Transactions
- Award
Common Stock
2014-02-27+4,400→ 28,400 total - Award
Stock Option (Right to Buy)
2014-02-27+26,300→ 26,300 totalExercise: $21.13Exp: 2024-02-27→ Common Stock (26,300 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Common Stock of AMAG Pharmaceuticals, Inc. (the "Issuer").
- [F2]These shares of Common Stock are issuable pursuant to a grant of restricted stock units pursuant to the Issuer's Third Amended and Restated 2007 Equity Incentive Plan (the "Plan") that vests over four years after the grant date as follows: (i) 25% on the first anniversary of the grant date and (ii) the balance vesting in equal annual installments over the next three years thereafter.
- [F3]Not applicable.
- [F4]Grant of stock option pursuant to the Plan. This option will vest and become exercisable over four years after the grant date as follows: (i) 25% vesting on the first anniversary of the grant date and (ii) the balance vesting in equal quarterly installments over the next three years thereafter.
Documents
Issuer
AMAG PHARMACEUTICALS INC.
CIK 0000792977
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000792977
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 5:39 PM ET
- Size
- 7.6 KB